These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7005539)

  • 21. Evaluation of bacteraemia in leprosy patients.
    Sreevatsa ; Sengupta U; Ramu G; Desikan KV
    Lepr India; 1978 Jul; 50(3):381-7. PubMed ID: 359927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology of a lepromatous eye.
    Ebenezer GJ; Daniel E
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):23-6. PubMed ID: 10834066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural features of the multiplication of human and murine leprosy bacilli in macrophages of nude mice.
    Fukunishi Y; Okada S; Nishiura M; Kohsaka K
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):68-75. PubMed ID: 7042613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of free-living pathogenic amoeba in the transmission of leprosy: a proof of principle.
    Lahiri R; Krahenbuhl JL
    Lepr Rev; 2008 Dec; 79(4):401-9. PubMed ID: 19274986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
    Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
    Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of Mycobacterium leprae in vitro for four years by lyophilization.
    Kohsaka K; Matsuoka M; Hirata T; Nakamura M
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):415-20. PubMed ID: 8228440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of Mycobacterium leprae and its viability in the peripheral blood of leprosy patients.
    Manja KS; Bedi BM; Kasturi G; Kirchheimer WF; Balasubrahmanyan M
    Lepr Rev; 1972 Dec; 43(4):181-7. PubMed ID: 4579979
    [No Abstract]   [Full Text] [Related]  

  • 28. The leprosy bacillus: a microbe-dependent microbe.
    Kato L
    Acta Leprol; 1987; 5(4):265-70. PubMed ID: 2831691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium leprae in cultured mouse peritoneal macrophages: in vivo infection-in vitro cultivation.
    Yang YT; Lew J
    Yonsei Med J; 1971; 12():1-12. PubMed ID: 4949821
    [No Abstract]   [Full Text] [Related]  

  • 30. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
    Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative assessment of viability of M.leprae by mouse foot-pad and fluorescent staining techniques.
    Sreevatsa ; Katoch VM
    Indian J Lepr; 1994; 66(4):455-62. PubMed ID: 7714355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of continuous bacillaemia in borderline and lepromatous type of leprosy.
    Raval SN; Sengupta U; Ramu G; Prabhune PV; Desikan KV
    Lepr India; 1982 Oct; 54(4):623-33. PubMed ID: 6763965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of radiometric macrophage assay and fluorescein diacetate/ethidium bromide staining for evaluation of M. leprae viability.
    Harshan KV; Prasad HK; Chopra NK; Mishra RS; Gogiya P; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):316-21. PubMed ID: 2439621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viable M. leprae as a research reagent.
    Truman RW; Krahenbuhl JL
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):1-12. PubMed ID: 11480310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium leprae upregulates IRGM expression in monocytes and monocyte-derived macrophages.
    Yang D; Chen J; Zhang L; Cha Z; Han S; Shi W; Ding R; Ma L; Xiao H; Shi C; Jing Z; Song N
    Inflammation; 2014 Aug; 37(4):1028-34. PubMed ID: 24469081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid, radiolabeled-microculture method that uses macrophages for in vitro evaluation of Mycobacterium leprae viability and drug susceptibility.
    Mittal A; Sathish M; Seshadri PS; Nath I
    J Clin Microbiol; 1983 Apr; 17(4):704-7. PubMed ID: 6343428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-10 treatment of macrophages bolsters intracellular survival of Mycobacterium leprae.
    Fukutomi Y; Matsuoka M; Minagawa F; Toratani S; McCormick G; Krahenbuhl J
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):16-26. PubMed ID: 15217319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human macrophage culture. The leprosy prognostic test (LPT).
    Barbieri TA; Correa WM
    Int J Lepr Other Mycobact Dis; 1967; 35(3):377-81. PubMed ID: 4917108
    [No Abstract]   [Full Text] [Related]  

  • 39. A new model for studying the effects of Mycobacterium leprae on Schwann cell and neuron interactions.
    Hagge DA; Oby Robinson S; Scollard D; McCormick G; Williams DL
    J Infect Dis; 2002 Nov; 186(9):1283-96. PubMed ID: 12402198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cultivation of M. leprae.
    Nakayama T
    Acta Leprol; 1984; 2(2-4):305-10. PubMed ID: 6398589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.